- Email: [email protected]
- Telephone: +39 02 67 04 275
- Fax: +39 02 67 03 250
- Website: http://www.botti-ferrari.com
Partner at Botti & Ferrari SpA
Rinaldo Ferreccio is a partner at Botti & Ferrari, a specialist IP law firm based in Milan.
Dr Ferreccio holds a degree in medicinal chemistry and a PhD in pharmaceutical sciences, both from the University of Genoa.
Dr Ferreccio is a qualified European patent attorney and industrial property counsel, and Italian patent and trademark attorney. He is also admitted to practise as a trademark attorney before the EU Intellectual Property Office and is a member of the International Association for the Protection of Intellectual Property Italy. He has also obtained a diploma in patent litigation in Europe from the University of Strasbourg.
Before joining Botti & Ferrari as a partner in 1999, Dr Ferreccio was a chemical researcher at Farmitalia-Carlo Erba (Milan), a substantive examiner at the European Patent Office (Munich) and a patent attorney at renowned Italian patent practices.
Dr Ferreccio speaks fluent English and has a sound knowledge of German and French.
Dr Ferreccio’s practice focuses mainly on the technical fields of medicinal chemistry, pharmaceutical technologies, organic chemistry, biochemistry, industrial chemistry, food chemistry, food technologies and biotechnology. His professional experience includes preparing and prosecuting European, international and foreign patent applications, carrying out prior art searches and providing technical opinions on patent validity and infringement. He has also acquired considerable experience as a court-appointed technical expert for patent litigation, in particular at the Milan Court.
Dr Ferreccio frequently provides technical assistance to attorneys at law in patent lawsuits and acts as a technical expert on behalf of his clients in Italian patent lawsuits.
Dr Ferreccio is frequently involved in nullity and infringement lawsuits concerning pharmaceutical substances and compositions involving prominent, often multinational, companies.